Description:
Bacterin-Vaccine
Canine
Parainfluenza-Bordetella bronchiseptica Vaccine, Modified Live Virus,
Avirulent Live Culture
Contents:
Canine parainfluenza,
modified live virus and Bordetella bronchiseptica, avirulent
live culture.
This vaccine
contains penicillin, streptomycin and nystatin as preservatives.
Indications:
INTRA-TRAC®-II is
recommended for use as an aid in the control and prevention of disease
associated with canine parainfluenza and Bordetella bronchiseptica
infection in healthy dogs 3 weeks of age or older. These agents have been
implicated as playing a role in the etiology of the condition known as
canine cough.
Dosage and
Administration:
Preparation of the
Vaccine:
1. Rehydrate the
vaccine with the accompanying sterile diluent.
2. Draw the
vaccine back into the syringe.
3. Remove needle
from syringe.
4. Apply nasal
applicator tip to syringe.
How to Vaccinate:
Instill the rehydrated vaccine into one or both nostrils of dogs as
illustrated below.
When to Vaccinate:
Vaccinate dogs at 3 weeks of age or older. Revaccinate annually.
Precaution(s):
Store at 2° to 7°C (35° to
45°F). Use entire contents when first opened. Burn containers and all unused
contents.
Caution(s):
This product is designed for
intranasal use only with the enclosed applicators. Systemic reactions
resulting from inadvertent intramuscular or subcutaneous injection have been
reported. Symptoms may include vomiting, diarrhea, lethargy, inappetence,
jaundice, and death associated with liver failure. Localized tissue necrosis
at the injection site has also been reported. If inadvertent injection
occurs, monitor the dog closely. Supportive therapy including IV fluids and
treatment with gentamicin, tetracycline or trimethoprim/sulfa may be
indicated.
Post vaccinal
reactions consisting of mild canine cough syndrome may occur following use
of this vaccine.
If anaphylactoid
reaction occurs, use epinephrine.
Warning(s):
For intranasal use only. For
veterinary use only.
Presentation:
25 x 1 mL single dose vials,
150 x 1 mL single dose vials, and 2 x 5 mL multiple dose vials, with sterile
diluent and nasal applicators.
|